Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).

Observational studies suggest that diabetes is associated with a decreased risk of prostate cancer, but few are population based or have investigated associations with cancer stage or duration of diabetes. We report a case-control study nested within the population-based Prostate testing for cancer...

Полное описание

Библиографические подробности
Главные авторы:	Turner, E, Lane, J, Donovan, J, Davis, M, Metcalfe, C, Neal, D, Hamdy, F, Martin, R
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
по: Collin, S, и др.
Опубликовано: (2009)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
по: Collin, S, и др.
Опубликовано: (2009)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
по: Hamdy, F, и др.
Опубликовано: (2006)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
по: Hamdy, F, и др.
Опубликовано: (2006)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
по: Rosario, D, и др.
Опубликовано: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
по: Rosario, D, и др.
Опубликовано: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
по: Rosario, D, и др.
Опубликовано: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
по: Avery, K, и др.
Опубликовано: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
по: Avery, K, и др.
Опубликовано: (2012)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
по: Neal, D, и др.
Опубликовано: (2006)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
по: Lane, J, и др.
Опубликовано: (2010)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
по: Macefield, R, и др.
Опубликовано: (2009)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
по: Dimitropoulou, P, и др.
Опубликовано: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
по: Dimitropoulou, P, и др.
Опубликовано: (2011)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
по: Rosario, D, и др.
Опубликовано: (2008)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
по: Lane, J, и др.
Опубликовано: (2007)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
по: Brindle, L, и др.
Опубликовано: (2006)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
по: Zuccolo, L, и др.
Опубликовано: (2013)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
по: J. Donovan, и др.
Опубликовано: (2003-01-01)

Prostate cancer: screening approaches.
по: Donovan, J, и др.
Опубликовано: (2005)

Prostate cancer: screening approaches
по: Donovan, J, и др.
Опубликовано: (2005)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
по: Lane, J, и др.
Опубликовано: (2007)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
по: Avery, K, и др.
Опубликовано: (2007)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
по: Walsh, E, и др.
Опубликовано: (2016)

Screening for prostate cancer remains controversial.
по: Neal, D, и др.
Опубликовано: (2009)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
по: Lane, J, и др.
Опубликовано: (2009)

Screening for prostate cancer. The case against.
по: Donovan, J, и др.
Опубликовано: (2005)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.
по: Macefield, R, и др.
Опубликовано: (2010)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
по: Harrison, S, и др.
Опубликовано: (2020)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
по: Moore, A, и др.
Опубликовано: (2009)

10-year outcomes in localized prostate cancer.
по: Hamdy, F, и др.
Опубликовано: (2017)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
по: Lane, J, и др.
Опубликовано: (2004)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
по: Avery, K, и др.
Опубликовано: (2008)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
по: Burton, A, и др.
Опубликовано: (2013)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
по: Hamdy, F, и др.
Опубликовано: (2003)

10-year outcomes in localized prostate cancer: Authors' reply
по: Hamdy, F, и др.
Опубликовано: (2017)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
по: Down, L, и др.
Опубликовано: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
по: Down, L, и др.
Опубликовано: (2011)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
по: Collin, S, и др.
Опубликовано: (2010)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
по: Williams, N, и др.
Опубликовано: (2011)